Our results are consistent with those reported by Oikonomou et al. [17] who noticed that the measurements of serum NGAL concentration can differentiate patients with IBD from healthy subjects or patients with irritable bowel syndrome. This evidence concerns the gene LCN2 and inflammatory bowel disease.